Financial News
Oncolytics Biotech Inc (NQ: ONCY )
1.110
-0.020
(-1.77%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
All News about Oncolytics Biotech Inc
Via Benzinga
Oncolytics Biotech: Q1 Earnings Insights
May 05, 2023
Via Benzinga
Oncolytics Biotech's Earnings: A Preview
March 02, 2023
Via Benzinga
Rise in Biotech Innovations Generating Hope as Pancreatic Cancer Survival Rates Climb
March 14, 2023
Exposures
Product Safety
Oncolytics Biotech's Earnings: A Preview
May 04, 2023
Via Benzinga
Wave of FDA Fast Track Designations Sparks Renewed Interest in Biotech Sector That’s Heating Up
December 01, 2022
Exposures
Product Safety
Biotech Sector Witnessing Growing Revenue Potential in Ongoing Battle Against Pancreatic Cancer
November 15, 2022
Topics
Death
Exposures
Death
Rising Incidence of Pancreatic Cancer Driving Demand for Advanced Treatment Therapies
November 07, 2022
Exposures
COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2022
October 06, 2022
Via Benzinga
R&D Efforts to Improve Optimal Treatments for Advanced Pancreatic Ductal Adenocarcinoma (PDAC) Progressing
October 05, 2022
Topics
Death
Exposures
Death
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.